Laboratory assay plate for cellular pathway research

Resveratrol Benefits for Health Conscious Adults: What 150–500 mg Does

Resveratrol has solid, human-trial support for lowering waist circumference, total cholesterol, and blood pressure in people with type 2 diabetes, plus moderate-certainty signals for glucose control and inflammation. What it doesn’t have is proof that it extends lifespan or prevents cancer in humans. The benefit you get depends heavily on your dose, the formulation you choose, and which outcome you’re targeting.

TL;DR:

  • Resveratrol at doses of 150 to 500 mg daily has strong evidence for reducing waist circumference, total cholesterol, and blood pressure in people with type 2 diabetes or for metabolic support.
  • Its effects on blood pressure are especially notable in diabetic populations, with systolic pressure decreasing by about 8 mmHg and diastolic by over 3 mmHg, sustained for several weeks.
  • While moderate-certainty evidence suggests improvements in glucose metabolism and liver fat markers, these benefits vary depending on the dose, duration, and individual health status.
  • The supplement’s bioavailability issues mean higher plasma levels are hard to achieve with standard doses, and formulation strategies have limited proven impact on clinical outcomes.
  • Resveratrol is safest and most justified for targeted use in individuals with specific health goals like high blood pressure or metabolic concerns, after consulting a healthcare professional.
Nexoclub
Explore Resveratrol Wellness Options
Browse NexoClub’s curated selection of health supplements, including products featuring resveratrol and other wellness ingredients.

Table of Contents

Resveratrol Benefits at a Glance: What’s Backed and What Isn’t

Not every claim about resveratrol carries the same weight of evidence. Some outcomes come from high-certainty umbrella reviews pooling multiple meta-analyses. Others rest on a handful of small trials or, worse, on cell studies that never made it to a human dosing trial. Here’s how the major claimed benefits stack up, with the dose ranges researchers actually tested.

  • Waist circumference reduction (high certainty): A large umbrella review found resveratrol supplementation reduced waist circumference by an average of 0.80 cm in overweight adults, using doses that typically ranged from 150 mg to 500 mg daily over 8 to 12 weeks.
  • Total cholesterol reduction (high certainty): The same review found a modest reduction in total cholesterol levels, generally at similar dose ranges.
  • Blood pressure reduction in type 2 diabetes (high certainty): Systolic and diastolic blood pressure showed clinically meaningful reductions in diabetic patients, usually at doses of 150 mg per day or higher, sustained for at least a month.
  • Glucose metabolism and insulin sensitivity (moderate certainty): Several trials link resveratrol to improved fasting glucose and HOMA-IR scores, though results vary by population and baseline metabolic health.
  • Endothelial and renal protection (moderate certainty): Markers of vascular and kidney function improved in some at-risk groups, with doses often in the 100 mg to 500 mg range.
  • Working memory (moderate certainty): A small number of trials found modest gains in memory tasks, mostly using higher daily doses over several weeks.
  • Hepatic steatosis improvement (moderate certainty): Some studies show liver fat reduction markers moving in a favorable direction, though sample sizes remain small.
  • Anti-inflammatory effects (moderate certainty): CRP and TNF-α reductions appear in trials lasting several months, particularly in populations with existing metabolic risk.

What jumps out is the pattern: the strongest evidence clusters around cardiovascular and metabolic markers, not the flashier anti-aging or brain-health claims most marketing leans on. That doesn’t make resveratrol useless. It makes it a supplement with a specific, evidence-backed lane rather than a cure-all. If you’re comparing it against other antioxidant options, this ranked breakdown of antioxidant supplements gives useful context for how resveratrol fits among its peers.

How Does Resveratrol Affect Heart Health?

Cardiovascular outcomes carry the most consistent human data of any resveratrol benefit category, and blood pressure is where the numbers are hardest to argue with.

In patients with type 2 diabetes, the umbrella review of systematic reviews and meta-analyses found average systolic blood pressure drops of 7.97 mmHg and diastolic drops of 3.55 mmHg. That’s a clinically meaningful shift, roughly comparable to what some lifestyle interventions achieve, and it showed up consistently enough across pooled trials to earn high-certainty status. The catch: this effect was strongest specifically in diabetic populations, not the general public, and typically required doses of 150 mg per day or more sustained for several weeks.

Blood pressure signal: Systolic and diastolic blood pressure decreased significantly in people with type 2 diabetes taking resveratrol, according to pooled trial data.

The mechanism behind this involves nitric oxide. Resveratrol appears to support endothelial function by promoting nitric-oxide-mediated vasodilation, which relaxes blood vessels and can ease pressure on arterial walls. Preclinical work from the Linus Pauling Institute also documents platelet-inhibiting effects, a plausible route to reduced thrombosis risk. There’s an important caveat here, though: the plasma concentrations needed to reproduce these effects in a test tube often exceed what a typical oral dose actually delivers into your bloodstream.

Lipid outcomes tell a similar story. Total cholesterol dropped by about 0.19 mmol/L in overweight adults across pooled trials, but the effect on LDL specifically and on triglycerides has been less consistent, with some trials showing no meaningful change.

Where things get murkier is with antiplatelet and anti-thrombosis effects in isolation. Cell and animal models show clear signals, but dedicated human trials measuring hard clotting endpoints (rather than surrogate markers) remain thin. Some clinical work has also flagged mild gastrointestinal upset at higher doses, which matters if you’re stacking resveratrol with other blood-thinning approaches.

  • Blood pressure: High-certainty reduction in type 2 diabetes patients, doses ≥150 mg/day.
  • Total cholesterol: High-certainty modest reduction in overweight adults.
  • LDL and triglycerides: Inconsistent results across trials.
  • Endothelial function and clotting markers: Improved in some trials, mechanistically plausible, but not universally replicated.

Does Resveratrol Improve Blood Sugar and Liver Health?

Metabolic outcomes represent one of resveratrol’s more consistently promising lanes, even if the certainty rating sits a notch below the cardiovascular findings.

Multiple trials report improved fasting glucose and HOMA-IR scores, the standard measure of insulin resistance, after several weeks of supplementation. The umbrella review classifies resveratrol’s effect on glucose metabolism as moderate-certainty evidence, meaning the direction of benefit is fairly reliable even though effect sizes vary trial to trial. Some studies also show improvements in HbA1c, the marker that reflects blood sugar control over roughly three months, though not every trial replicates this.

The proposed mechanism runs through two well-studied cellular pathways: SIRT1 and AMPK. Activating SIRT1 is thought to influence how cells manage energy and stress responses, while AMPK activation nudges cells toward burning fat and glucose more efficiently. Anti-inflammatory activity likely plays a supporting role too, since chronic low-grade inflammation is tightly linked to insulin resistance. It’s worth being direct about a limitation here: most of the mechanistic detail comes from cell and animal studies, and the concentrations used in those experiments frequently exceed what oral supplementation achieves in a person’s bloodstream.

For liver health, the picture is narrower but genuinely interesting. The same umbrella review notes moderate-certainty evidence that resveratrol may improve hepatic steatosis, the fatty buildup in liver cells associated with non-alcoholic fatty liver disease. This lines up with the antioxidant and anti-inflammatory mechanisms discussed above, since oxidative stress and inflammation both drive fat accumulation in liver tissue. If liver health specifically is your concern, it’s worth reading a broader evidence-based guide to liver support supplements to see how resveratrol compares to other options in that category.

  • Fasting glucose: Moderate-certainty improvement across several trials.
  • Insulin sensitivity (HOMA-IR): Consistent directional improvement, variable magnitude.
  • HbA1c: Improvement in some but not all trials.
  • Hepatic steatosis: Moderate-certainty improvement, plausible via reduced oxidative stress.

Trial durations for these metabolic outcomes ranged widely, from a few weeks to several months, and doses spanned low tens of milligrams up to multiple grams daily. That heterogeneity is exactly why researchers describe the evidence as moderate rather than high. Different doses, different trial lengths, and different baseline health statuses all pull the pooled results in different directions.

Can Resveratrol Protect Brain Function and Memory?

This is where the gap between preclinical enthusiasm and human proof is widest. Animal and cell models paint resveratrol as broadly neuroprotective, but the human data supporting cognitive benefits is thin and narrowly focused.

A small number of human trials have found measurable improvements in working memory after resveratrol supplementation, and the umbrella review lists this as a moderate-certainty outcome. That’s a real, if limited, signal worth taking seriously if cognitive support is a personal priority. But it stops well short of supporting claims about preventing dementia or Alzheimer’s disease, which remain unestablished in human trials despite considerable interest.

The mechanistic story is compelling on paper. Resveratrol is small and lipophilic enough to cross the blood brain barrier in animal models, and some research points to interactions with amyloid clearance pathways, the process by which the brain removes the protein plaques associated with Alzheimer’s pathology. Preclinical work also documents antioxidant activity inside brain tissue itself, which theoretically could slow the oxidative damage linked to neurodegeneration.

Here’s the honest caveat: the narrative review of resveratrol’s molecular mechanisms is direct about the fact that many of these neuroprotective and longevity-adjacent claims are based primarily on preclinical models. Translating a rat study into a confident human recommendation is a leap the current data doesn’t support.

  • Working memory: Moderate-certainty improvement in limited human trials.
  • Dementia prevention/treatment: Not established in humans; promising signal exists mainly in animal models.
  • Blood brain barrier penetration: Demonstrated in preclinical studies, not confirmed at typical human oral doses.
  • Amyloid clearance: Plausible mechanism under investigation, no confirmed clinical outcome data yet.

If cognitive preservation is your main goal, treat resveratrol as a possible complement to established approaches, not a replacement for them. Readers exploring hormone-related cognitive changes, particularly around menopause, might also find this review of plant-based menopause supplements useful, since some resveratrol trials have specifically studied menopausal populations.

The Cellular Pathways Behind Resveratrol’s Effects

Nearly every claimed resveratrol benefit traces back to a small set of cellular pathways, and understanding them helps explain why the supplement shows such a wide range of effects from one trial to the next.

SIRT1 is a protein involved in regulating cellular stress responses and metabolism. Resveratrol is one of the most studied natural activators of this pathway, and its influence on SIRT1 is thought to connect to several of the metabolic and cardiovascular benefits already discussed.

AMPK functions as a kind of cellular energy sensor. When activated, it shifts cells toward burning stored fuel rather than storing more of it, which lines up with the glucose and insulin sensitivity improvements seen in some trials.

Nrf2 governs the body’s internal antioxidant defense system, switching on genes that produce protective enzymes when cells encounter oxidative stress. This pathway helps explain resveratrol’s antioxidant reputation beyond simply neutralizing free radicals directly.

NF-κB is a master regulator of inflammation. Resveratrol appears to dampen NF-κB signaling, which tracks with the reductions in inflammatory markers like CRP and TNF-α observed in some human trials, according to the narrative review on resveratrol’s molecular mechanisms.

These four pathways aren’t isolated switches. They overlap and reinforce each other, which is part of why resveratrol shows effects across such different body systems, from arteries to liver cells to joints. But there’s a persistent asterisk on all of it: the concentrations of resveratrol needed to meaningfully activate these pathways in a lab dish often run higher than what standard oral dosing achieves in human plasma. That mismatch is the central tension running through nearly every resveratrol study published to date.

Four resveratrol cellular pathways and evidence gap

Resveratrol Dosage, Safety, and Drug Interactions

Human trials have tested an unusually wide dosage spread, which makes it hard to point to one “correct” dose. Here’s what the clinical literature actually used.

  1. Low-dose trials (8 mg to 150 mg daily): Often used for general antioxidant or metabolic support studies, typically over 8 to 12 weeks.
  2. Moderate-dose trials (150 mg to 500 mg daily): The range most associated with blood pressure and cholesterol improvements in the umbrella review.
  3. High-dose trials (1,000 mg to 3,000 mg daily): Used in some metabolic and inflammatory marker studies, with a higher incidence of mild gastrointestinal side effects.
  4. Extreme-dose trials (up to 5,000 mg daily): Tested in a small number of trials primarily to establish safety ceilings rather than to find optimal therapeutic effect, according to the review covering resveratrol dosing and clinical evidence.

The most commonly reported side effects at higher doses are gastrointestinal: nausea, diarrhea, and general stomach upset. These tend to be mild and dose-dependent, meaning they show up more reliably as the dose climbs into the gram range rather than at the modest 150 mg to 500 mg levels used in most cardiovascular trials.

The interaction that deserves the most attention involves blood thinning. Resveratrol’s antiplatelet activity, the same mechanism that may support cardiovascular health, also means it could theoretically amplify the effect of anticoagulant or antiplatelet medications like warfarin or aspirin. If you’re on any blood-thinning medication, this is a conversation to have with your prescriber before adding resveratrol, not after.

There’s also a metabolic interaction worth flagging: resveratrol can influence how the liver processes certain drugs through cytochrome P450 enzymes, which means it has the theoretical potential to alter blood levels of medications metabolized through the same pathway. This isn’t a reason to panic, but it is a reason to disclose supplement use to your pharmacist or doctor rather than treating it as a harmless add-on.

Pro Tip: Start at the lower end of the trial-tested range, around 150 mg daily, and hold there for at least four to six weeks before judging whether it’s doing anything. Jumping straight to gram-level doses because “more is better” is exactly how people end up with the GI side effects that show up most often in high-dose trials.

None of this is a substitute for individualized medical advice. If you take prescription medication or manage a chronic condition, talk to a clinician before starting resveratrol.

Resveratrol Dosage, Safety, and Drug Interactions — overview diagram

Why Bioavailability Limits What Resveratrol Supplements Can Actually Do

Resveratrol has a bioavailability problem, and it’s the single biggest reason human results often undershoot what cell and animal studies promise. Once swallowed, resveratrol gets rapidly metabolized in the liver and intestinal wall, converting much of it into glucuronide and sulfate compounds before it ever reaches meaningful circulation. The review on resveratrol’s bioavailability and formulation challenges identifies this rapid metabolism as a central obstacle to translating lab-dish results into consistent human outcomes.

This is why formulation has become its own mini research field. A few approaches show up repeatedly in the literature:

  • Piperine co-administration: Black pepper extract is sometimes paired with resveratrol because piperine can inhibit some of the enzymes responsible for breaking it down, potentially extending its time in circulation.
  • Liposomal delivery: Wrapping resveratrol in lipid vesicles is designed to protect it during digestion and improve absorption across the gut lining.
  • Nanoemulsion and nanoencapsulation: Reducing particle size to the nanoscale aims to increase surface area and absorption rate.

The honest state of the evidence: these formulation strategies show genuine promise in preclinical pharmacokinetic studies, but human outcome data proving they produce meaningfully better clinical results, not just better blood levels, remains limited. A formulation can raise plasma resveratrol levels without necessarily proving it improves blood pressure or glucose control any better than standard capsules did in the trials that established those benefits in the first place.

Pro Tip: If you’re comparing supplements, look past the marketing claims about “enhanced absorption” and check whether the brand cites actual human pharmacokinetic data, not just a cell-culture or rodent study. Third-party testing for purity and actual resveratrol content also matters more than the delivery-system buzzwords on the label.

For readers weighing resveratrol against other antioxidant strategies, it’s worth noting that formulation challenges aren’t unique to this compound. CoQ10 faces similar absorption hurdles, and comparing how different supplements address bioavailability can help you evaluate any product’s claims more critically.

Who Should Actually Consider Taking Resveratrol?

Not every health-conscious adult needs this supplement, and matching your goal to the evidence matters more than following a trend.

Good candidates based on current evidence:

  • Adults with elevated blood pressure or existing type 2 diabetes, where the strongest data exists.
  • Overweight adults looking for modest support with waist circumference and total cholesterol alongside diet and exercise.
  • People with early markers of hepatic steatosis who are already working with a clinician on liver health.
  • Those interested in general antioxidant and anti-inflammatory support as part of a broader wellness routine, with realistic expectations.

Who should be more cautious:

  • Anyone on blood-thinning medication, given the theoretical antiplatelet interaction.
  • Pregnant or breastfeeding individuals, since safety data in these groups is limited.
  • Anyone expecting resveratrol to meaningfully prevent cancer or dementia, since human evidence doesn’t support that expectation yet.

A simple decision checklist before starting:

  1. Identify your specific goal (blood pressure, metabolic markers, general antioxidant support).
  2. List current medications and flag any blood thinners or liver-metabolized drugs.
  3. Talk to your clinician about whether resveratrol fits your health picture.
  4. Start at a modest dose, generally in the 150 mg range, based on trial-tested amounts.
  5. Set a monitoring period of 8 to 12 weeks and track the specific marker you’re targeting, not just how you feel.

What Umbrella Reviews and RCTs Tell Us About Resveratrol

The clearest picture of resveratrol’s real-world value comes from umbrella reviews, which pool data across multiple systematic reviews and meta-analyses rather than relying on any single trial.

The umbrella review of randomized controlled trials found high-certainty evidence for three outcomes: reduced waist circumference, lowered total cholesterol, and reduced systolic and diastolic blood pressure in type 2 diabetes patients. Effect sizes were real but modest, a waist circumference reduction of 0.80 cm and a total cholesterol drop of 0.19 mmol/L, not dramatic transformations.

Moderate-certainty evidence extends further: improved glucose metabolism, better renal function, enhanced endothelial health, gains in working memory, improved hepatic steatosis, and reduced inflammation all showed up across the pooled trials, though with more variability than the high-certainty outcomes.

The research gaps that matter most for practice: trial durations and doses varied enormously, which limits how confidently anyone can recommend one specific protocol. Bioavailability differences between studies likely explain some of the inconsistency between trials testing similar doses. Until formulation research catches up with the mechanistic promise, expect benefits to stay modest and outcome-specific rather than sweeping.

What About Resveratrol’s Role in Cancer Prevention?

Cell and animal studies have generated substantial interest in resveratrol as a potential anti-cancer compound, largely because it demonstrates antioxidant and anti-inflammatory activity that theoretically could interfere with processes tumors rely on to grow and spread. Some laboratory research points to effects on cell signaling pathways involved in abnormal cell growth.

Here’s where the evidence sharply narrows once you move from petri dish to patient. Human clinical trials testing resveratrol specifically for cancer prevention or as a treatment adjunct remain limited, and the narrative review of resveratrol’s molecular mechanisms is explicit that many of the anti-cancer claims circulating in supplement marketing rest primarily on preclinical models rather than confirmed human outcomes.

This gap matters because the doses and delivery methods that show anti-cancer activity in cell cultures often bear little resemblance to what a standard oral supplement achieves in human blood. Cancer biology is also enormously heterogeneous. What shows promise against one cell line in a lab dish doesn’t necessarily translate to any specific cancer type in a living person, let alone across the dozens of distinct cancers researchers study.

The responsible takeaway: resveratrol should not be treated as a cancer prevention strategy or, worse, as an alternative to established medical treatment for anyone with an active cancer diagnosis. If you’re undergoing cancer treatment, discuss any supplement, resveratrol included, with your oncology team first, since interactions with chemotherapy agents or radiation sensitivity aren’t fully mapped out in human studies.

How Does Resveratrol Affect Immune System Function?

Resveratrol’s relationship with immune function runs through the same anti-inflammatory pathways discussed earlier, particularly its influence on NF-κB signaling and inflammatory markers like CRP and TNF-α. In theory, an antioxidant compound that dampens chronic low-grade inflammation could support a more balanced immune response, since persistent inflammation is linked to immune dysregulation over time.

Human evidence directly measuring immune function outcomes, rather than just inflammatory blood markers, is still sparse. Trials that report reduced CRP and TNF-α levels give an indirect signal that resveratrol may support a calmer, less inflamed immune environment, but that’s a different claim than proving improved infection resistance or vaccine response, which haven’t been well studied in dedicated human trials.

There’s also a nuance worth understanding: immune function isn’t a single dial that goes up or down. Resveratrol’s antioxidant activity might help modulate an overactive inflammatory response in one context while having no measurable effect on, say, how quickly you clear a common cold. Without trials designed around infection outcomes specifically, it’s premature to describe resveratrol as an immune booster in the way that phrase gets used in supplement marketing.

The realistic framing is this: resveratrol’s anti-inflammatory activity is one of its better-supported mechanisms, and inflammation control is genuinely connected to long-term immune health. But treat “supports a healthy inflammatory response” as the accurate claim, not “boosts immunity,” since the latter implies a level of specific human proof that doesn’t currently exist.

What Do We Know About Long-Term Safety?

Most resveratrol trials run anywhere from a few weeks to several months, which means long-term safety data, spanning years rather than months, is genuinely thin. This is an important gap for anyone considering resveratrol as a daily, indefinite supplement rather than a short-term intervention.

Within the trial durations that have been studied, resveratrol has shown a reasonably clean safety profile at moderate doses. The review covering resveratrol dosing and clinical evidence notes that even at doses up to 5,000 mg daily, tested specifically to probe safety limits, side effects were mostly mild and gastrointestinal rather than serious.

What’s missing is data on what happens with continuous daily use over years, particularly regarding kidney function, liver enzymes, and hormonal effects, since resveratrol has some structural similarity to estrogen and interacts with estrogen receptor pathways in preclinical models. This raises a legitimate question for anyone with a hormone-sensitive condition, and it’s a conversation worth having with a clinician rather than assuming supplement status equals automatic safety.

The practical stance: resveratrol looks safe across the trial durations studied so far, but “safe for 12 weeks” and “safe for 10 years of daily use” are different claims, and only the first one currently has real backing. If you plan to use it long-term, periodic check-ins with a healthcare provider, particularly around liver and kidney markers, are a reasonable precaution rather than an overreaction.

Does Resveratrol Actually Slow Aging?

Resveratrol’s reputation as an anti-aging compound traces back to early cell studies linking it to sirtuin activation and, by extension, to the biology of caloric restriction, a well-documented longevity intervention in animal models. That connection generated enormous interest and, frankly, oversold expectations.

The human reality is more modest. None of the high or moderate-certainty outcomes from the umbrella review directly measure lifespan or biological aging markers in humans. What resveratrol does show, reduced waist circumference, lower blood pressure, improved cholesterol, and reduced inflammation, are all risk factors connected to age-related disease, which is a meaningfully different claim than “slows aging” itself.

This distinction matters because those risk-factor improvements are genuinely useful on their own terms. Managing blood pressure and inflammation over decades plausibly supports healthier aging, even without a direct anti-aging mechanism proven in humans. But that’s an indirect path, built on managing known risk factors, not a demonstrated effect on the aging process itself.

The mechanistic story involving SIRT1 activation and mimicking caloric restriction remains compelling and is still an active area of research, but it hasn’t cleared the bar of confirmed human longevity outcomes. If anti-aging benefits are your main interest, resveratrol may support skin and cardiovascular markers connected to aging, and it’s worth reviewing how antioxidants function in skin aging specifically to set expectations around what topical versus oral antioxidant strategies can and can’t do.

How NexoClub Thinks About Resveratrol Products

We built our approach to supplement selection around a simple rule: match the marketing to what trials actually show, not to what sounds impressive on a label. That means favoring formulations with disclosed dosing that lines up with the ranges studied in clinical research, rather than proprietary blends that hide the actual resveratrol content.

We also lean on educational resources like this one, and on other evidence-based product write-ups on the site, because we think shoppers make better decisions when they understand the mechanism and the limitation, not just the promise. Resveratrol is a good example of a supplement worth taking seriously without taking it on faith.

If you’re shopping for resveratrol or any supplement in this category, check the dose against trial-tested ranges, and talk to your doctor before starting, especially if you take other medications.

— Armando

NexoClub’s NAD+ Booster with Resveratrol

If the evidence above has you leaning toward supplementation, Nexoclub carries a resveratrol-containing formula built with dosing transparency in mind rather than vague proprietary blends. The NAD+ Booster with Resveratrol pairs resveratrol with NAD+ support ingredients aimed at cellular energy and healthy aging support, formulated for readers who want a clearly labeled starting point rather than guessing between dozens of unlabeled options.

No claims are made that this formula cures anything or replaces medical treatment. It offers a straightforward, disclosed formulation you can check against the dose ranges discussed throughout this article, and weigh against your own goals with your clinician. Browse the full supplements and nutrition collection to compare options, check the product label against your target dose, and confirm with your doctor before adding it to your routine.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

Sources

Grape skins, red wine, peanuts, blueberries, and cranberries all contain resveratrol naturally, but the amounts are modest compared to the doses used in most clinical trials. A glass of red wine typically delivers a small fraction of a milligram to a few milligrams of resveratrol, nowhere close to the 150 mg or higher doses that produced blood pressure and cholesterol improvements in trial settings. Peanuts and berries contribute even smaller amounts per typical serving.

That gap matters for how you think about strategy. Getting clinically meaningful resveratrol intake from food alone, at the doses studied in trials, is not realistic through diet.

That doesn’t make food sources pointless. Whole foods deliver resveratrol alongside a broader package of polyphenols, fiber, and other nutrients that likely work together rather than in isolation, an advantage a purified supplement can’t replicate. For most people focused on general wellness rather than a specific clinical target, a food-first approach makes practical sense: emphasize grapes, berries, and peanuts as part of a varied diet, and treat that as your baseline.

Supplementation becomes more reasonable to consider when you have a specific, measurable goal, elevated blood pressure, metabolic markers trending the wrong way, or a clinician-monitored target, and you want to reach the dose ranges that actually showed effects in trials. In that case, discuss a starting dose and a monitoring plan with your healthcare provider rather than guessing based on a label.

Back to blog